Loading data for RVTY — first visit, this takes a few seconds.

Alerta

Revvity Inc. (RVTY)

NYSE: RVTY · Precio en tiempo real · USD

128.80

-0.91 (-0.70%)

Al cierre: Aug 28, 2026, 8:00 PM

127.20

-1.24%

Fuera de horario: 7:49 PM

El precio, las cifras principales y las últimas noticias, en un solo sitio.

-0.70% (1D)

No hay datos disponibles

Precio de compra	128.51
Capitalización de mercado	14.37B
Ingresos (TTM)	2.91B
Beneficio neto (TTM)	237.37M
	1.07
	2.07
	62.52
	21.86
P/B (TTM)	1.99
P/S (TTM)	4.94
Fecha de resultados	Oct 26, 2026

Precio de venta	128.62
Volumen	1,576,262
Volumen medio (20D)	1,466,211
Abierto	128.57
Anterior Cerrar	129.71
Rango del día	127.26 - 130.07
Rango de 52 semanas	81.22 - 130.07
analista	n/a
Precio objetivo	n/a
Dividendos	$0.28 (0.22%)
Fecha ex dividendo	23 oct 2026

Acerca de RVTY

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its p...

[Leer más]

Industria Diagnostics & Research

Sector Healthcare

IPO Fecha Feb 21, 1973

Empleados 11,000

Bolsa de Valores NYSE

Símbolo bursátil RVTY

Sitio web https://www.revvity.com

Perfil completo de la empresa

Desempeño financiero

En 2025, los ingresos de Revvity fueron 2.86B, un aumento de 3.67% en comparación con 2.76B del año anterior. Las ganancias fueron 241.2M, una disminución de -10.79%.

Estados financieros

Sorpresa de resultados

Revvity ha publicado sus resultados trimestrales en Aug 4, 2026:

Ingresos de n/a falla las estimaciones por $0, con -100.00% Disminución interanual.
EPS de 1.41 supera las estimaciones en 0.19, con 19.49% Crecimiento interanual.

Próxima publicación de resultados

Está previsto que Revvity Inc. publique sus resultados el Oct 26, 2026, antes de que se abra el mercado.
Los analistas proyectan ingresos de ... Actualizar

Noticias

6 días hace · Zacks

Is the Options Market Predicting a Spike in Revvity Stock?

Investors need to pay close attention to RVTY stock based on the movements in the options market lately.

6 días hace · Barchart

Revvity Stock: Is Wall Street Bullish or Bearish?

Revvity has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.

2 semanas hace · Zacks

Revvity Launches SuperFlex Prenatal Screening System for Smaller Labs

RVTY launches SuperFlex, a compact automated prenatal screening system aimed at expanding rapid in-house testing for smaller labs and clinics.

2 semanas hace · StockStory

The Top 5 Analyst Questions From Revvity’s Q2 Earnings Call

Revvity’s second quarter demonstrated year-over-year growth in both revenue and non-GAAP earnings, yet the market responded negatively, likely reflecting concerns about underlying segment dynamics and...

2 semanas hace · Motley Fool

Revvity (RVTY) Q2 2026 Earnings Call Transcript

Diagnostics surged 11% organically as AI-driven demand accelerated.

Página 1 de 2